Rangeley-Capital

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
73
Total Value
92052366
Accession Number
0000919574-25-003019
Form Type
13F-HR
Manager Name
Rangeley-Capital
Data Enrichment
82% identified
60 identified13 unidentified

Holdings

73 positions • $92.1M total value
Manager:
Search and click to pin securities to the top
Page 4 of 4
Trilogy Metals Inc.
Shares:98.1K
Value:$152.0K
% of Portfolio:0.2% ($152.0K/$92.1M)
First Seacoast Bancorp, Inc.
Shares:13.0K
Value:$151.4K
% of Portfolio:0.2% ($151.4K/$92.1M)
WM TECHNOLOGY, INC.
Shares:125.0K
Value:$141.3K
% of Portfolio:0.2% ($141.3K/$92.1M)
Esperion Therapeutics, Inc.
Shares:92.5K
Value:$133.2K
% of Portfolio:0.1% ($133.2K/$92.1M)
65341B106
Shares:12.2K
Value:$115.9K
% of Portfolio:0.1% ($115.9K/$92.1M)
GAN Ltd
Shares:59.9K
Value:$106.0K
% of Portfolio:0.1% ($106.0K/$92.1M)
33833Q106
Shares:14.9K
Value:$79.3K
% of Portfolio:0.1% ($79.3K/$92.1M)
SURO CAPITAL CORP.
Shares:14.9K
Value:$74.3K
% of Portfolio:0.1% ($74.3K/$92.1M)
AN2 Therapeutics, Inc.
Shares:50.0K
Value:$68.0K
% of Portfolio:0.1% ($68.0K/$92.1M)
PLIANT THERAPEUTICS, INC.
Shares:50.0K
Value:$67.5K
% of Portfolio:0.1% ($67.5K/$92.1M)
PepGen Inc.
Shares:15.0K
Value:$21.1K
% of Portfolio:0.0% ($21.1K/$92.1M)
586001109
Shares:1.4K
Value:$8.7K
% of Portfolio:0.0% ($8.7K/$92.1M)
Lyell Immunopharma, Inc.
Shares:10.0K
Value:$5.4K
% of Portfolio:0.0% ($5.4K/$92.1M)